Beijing Rareplus MedTech Co., Ltd.

SPEROGENIX

Medicines for human purposes, namely, medicines for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; Pharmaceutical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; Chemico-pharmaceutical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; Chemical preparations for pharmaceutical purposes for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; chemical preparations for medical purposes, namely, chemical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; Biochemical drugs in the nature of pharmaceutical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; diagnostic preparations for medical purposes; dietetic foods adapted for medical purposes;

SPEROGENIX

Technological research in the field of pharmaceutical development, pharmaceutical chemistry, and biotechnology; Conducting technical project studies for research purposes in the field of pharmaceutical chemistry and biotechnology; Research and development of new products for others; Scientific laboratory services; Chemistry services, namely, pharmaceutical chemistry research; Chemical research; Biological research; Computer programming; Computer software design; Computer software consultancy;